358 lines (357 with data), 11.7 kB
T1 Age 2 13 42 year-old
T3 Disease_disorder 31 51 lymphocytic leukemia
E1 Disease_disorder:T3
T4 Detailed_description 23 30 chronic
R1 MODIFY Arg1:T4 Arg2:E1
T5 Therapeutic_procedure 73 95 bone marrow transplant
E2 Therapeutic_procedure:T5
T6 Detailed_description 62 72 allogeneic
R2 MODIFY Arg1:T6 Arg2:E2
T7 Date 99 113 September 2013
E3 Date:T7
T8 Coreference 119 124 graft
E4 Coreference:T8
R3 IDENTICAL Arg1:E4 Arg2:E2
T9 Activity 2994 2998 died
E5 Activity:T9
T10 Date 3006 3016 end of May
E6 Date:T10
T2 Sex 14 17 man
T11 Detailed_description 129 182 mismatched at a single human leukocyte antigen allele
T12 Medication 229 240 alemtuzumab
E7 Medication:T12
T13 Detailed_description 199 214 T-cell depleted
#1 AnnotatorNotes T13 technically not a procedure done to the patient, but the transplanted cells
R4 MODIFY Arg1:T11 Arg2:E4
R5 MODIFY Arg1:T13 Arg2:E4
R6 MODIFY Arg1:E7 Arg2:T13
T14 Therapeutic_procedure 245 254 engrafted
E8 Therapeutic_procedure:T14
T15 Date 258 264 day 12
E9 Date:T15
T16 Therapeutic_procedure 271 281 transplant
E10 Therapeutic_procedure:T16
T17 Sign_symptom 305 316 lymphopenia
E11 Sign_symptom:T17
T18 Detailed_description 294 304 persistent
R7 MODIFY Arg1:T18 Arg2:E11
T19 Sign_symptom 321 329 diarrhea
E12 Sign_symptom:T19
T20 Disease_disorder 335 344 norovirus
E13 Disease_disorder:T20
R8 CAUSE Arg1:E13 Arg2:E12
R9 CAUSE Arg1:E13 Arg2:E11
T21 Diagnostic_procedure 360 381 posttransplant course
E14 Diagnostic_procedure:T21
T22 Lab_value 386 398 unremarkable
E15 Lab_value:T22
R10 MODIFY Arg1:E15 Arg2:E14
T23 Date 405 416 mid-October
E16 Date:T23
T24 Sign_symptom 435 443 tinnitus
E17 Sign_symptom:T24
T25 Disease_disorder 468 490 sensorineural deafness
E18 Disease_disorder:T25
A1 TREND E18 INC
T26 Detailed_description 448 467 rapidly progressive
R11 MODIFY Arg1:T26 Arg2:E18
T27 Sign_symptom 514 526 hearing loss
E19 Sign_symptom:T27
T29 Lab_value 540 546 >95 dB
E21 Lab_value:T29
T30 Detailed_description 505 513 subtotal
T28 Detailed_description 527 538 bilaterally
R12 MODIFY Arg1:T28 Arg2:E19
R13 MODIFY Arg1:T30 Arg2:E19
R14 MODIFY Arg1:E21 Arg2:E19
T31 Duration 548 562 over 2–3 weeks
E20 Duration:T31
T32 Diagnostic_procedure 570 596 magnetic resonance imaging
E22 Diagnostic_procedure:T32
T33 Biological_structure 564 569 Brain
R15 MODIFY Arg1:T33 Arg2:E22
T34 Diagnostic_procedure 598 601 MRI
E23 Diagnostic_procedure:T34
R16 IDENTICAL Arg1:E23 Arg2:E22
T35 Diagnostic_procedure 628 647 cerebrospinal fluid
E24 Diagnostic_procedure:T35
T36 Diagnostic_procedure 649 652 CSF
E25 Diagnostic_procedure:T36
R17 IDENTICAL Arg1:E25 Arg2:E24
T37 Diagnostic_procedure 689 700 neutrophils
E26 Diagnostic_procedure:T37
T38 Diagnostic_procedure 709 720 lymphocytes
E27 Diagnostic_procedure:T38
T39 Lab_value 664 679 4 leukocytes/µL
E28 Lab_value:T39
R18 MODIFY Arg1:E28 Arg2:E24
T40 Lab_value 685 688 50%
E29 Lab_value:T40
T41 Lab_value 705 708 50%
E30 Lab_value:T41
R19 MODIFY Arg1:E29 Arg2:E26
R20 MODIFY Arg1:E30 Arg2:E27
R21 SUB_PROCEDURE Arg1:E26 Arg2:E24
R22 SUB_PROCEDURE Arg1:E27 Arg2:E24
T42 Lab_value 722 742 6 red blood cells/µL
E31 Lab_value:T42
R23 MODIFY Arg1:E31 Arg2:E24
T43 Diagnostic_procedure 744 751 glucose
E32 Diagnostic_procedure:T43
T44 Diagnostic_procedure 851 868 oligoclonal bands
E33 Diagnostic_procedure:T44
T45 Lab_value 840 847 absence
E34 Lab_value:T45
R24 MODIFY Arg1:E34 Arg2:E33
T46 Diagnostic_procedure 795 802 protein
E35 Diagnostic_procedure:T46
T47 Lab_value 752 762 2.4 mmol/L
E36 Lab_value:T47
T48 Lab_value 803 811 61 mg/dL
E37 Lab_value:T48
R25 MODIFY Arg1:E37 Arg2:E35
R26 MODIFY Arg1:E36 Arg2:E32
R27 SUB_PROCEDURE Arg1:E32 Arg2:E24
R28 SUB_PROCEDURE Arg1:E35 Arg2:E24
R29 SUB_PROCEDURE Arg1:E33 Arg2:E24
T49 Diagnostic_procedure 877 902 polymerase chain reaction
E38 Diagnostic_procedure:T49
T50 Detailed_description 920 923 CSF
R30 MODIFY Arg1:T50 Arg2:E38
T51 Detailed_description 871 876 Viral
R31 MODIFY Arg1:T51 Arg2:E38
#2 AnnotatorNotes T51 testing for viral DNA; the test itself is not viral
T52 Medication 1031 1043 valacyclovir
E39 Medication:T52
T53 Medication 1060 1071 antibiotics
E40 Medication:T53
T54 Medication 1096 1110 immunoglobulin
E41 Medication:T54
T55 Sign_symptom 1185 1192 dyspnea
E42 Sign_symptom:T55
T56 Sign_symptom 1203 1214 hypotension
E43 Sign_symptom:T56
T57 Sign_symptom 1216 1222 nausea
E44 Sign_symptom:T57
T58 Diagnostic_procedure 1248 1255 balance
E45 Diagnostic_procedure:T58
T59 Lab_value 1228 1247 gradually worsening
E46 Lab_value:T59
R32 MODIFY Arg1:E46 Arg2:E45
T60 Disease_disorder 941 952 enterovirus
E47 Disease_disorder:T60
A2 POLARITY E47 NEG
T61 Disease_disorder 957 968 herpesvirus
E48 Disease_disorder:T61
A3 POLARITY E48 NEG
T62 Dosage 1077 1083 2 g/kg
R33 MODIFY Arg1:T62 Arg2:E41
T63 Administration 1084 1095 intravenous
R34 MODIFY Arg1:T63 Arg2:E41
T64 Medication 1112 1116 IVIG
E49 Medication:T64
R35 IDENTICAL Arg1:E49 Arg2:E41
T65 Diagnostic_procedure 1264 1287 neurological assessment
E50 Diagnostic_procedure:T65
T66 Disease_disorder 1309 1338 vestibulocochlear dysfunction
E51 Disease_disorder:T66
T67 Detailed_description 1298 1308 persistent
R36 MODIFY Arg1:T67 Arg2:E51
T68 Date 1339 1352 6 weeks after
E52 Date:T68
T69 Date 1371 1383 mid-December
E53 Date:T69
T70 Sign_symptom 1421 1430 withdrawn
E54 Sign_symptom:T70
T71 Sign_symptom 1432 1441 irritable
E55 Sign_symptom:T71
T72 Sign_symptom 1462 1470 agitated
E56 Sign_symptom:T72
T73 Detailed_description 1447 1461 intermittently
R37 MODIFY Arg1:T73 Arg2:E56
A4 TREND E54 INC
A5 TREND E55 INC
A6 TREND E56 INC
T74 Sign_symptom 1484 1495 lymphopenic
E57 Sign_symptom:T74
T75 Diagnostic_procedure 1497 1508 lymphocytes
E58 Diagnostic_procedure:T75
T76 Lab_value 1509 1522 0.54 × 106/μL
E59 Lab_value:T76
R38 MODIFY Arg1:E59 Arg2:E58
T77 Diagnostic_procedure 1558 1561 MRI
E60 Diagnostic_procedure:T77
T78 Biological_structure 1575 1580 brain
T79 Lab_value 1586 1598 unremarkable
E61 Lab_value:T79
R39 MODIFY Arg1:T78 Arg2:E60
R40 MODIFY Arg1:E61 Arg2:E60
T80 Diagnostic_procedure 1625 1648 antineuronal antibodies
E62 Diagnostic_procedure:T80
T81 Detailed_description 1607 1620 serum testing
R41 MODIFY Arg1:T81 Arg2:E62
R42 MODIFY Arg1:E61 Arg2:E62
T82 Diagnostic_procedure 1653 1673 electroencephalogram
E63 Diagnostic_procedure:T82
T83 Disease_disorder 1696 1710 encephalopathy
E64 Disease_disorder:T83
T84 Disease_disorder 1744 1749 viral
E65 Disease_disorder:T84
A7 POLARITY E65 UNCERTAIN
T85 Medication 1799 1814 glucocorticoids
E66 Medication:T85
T86 Dosage 1789 1798 high-dose
R43 MODIFY Arg1:T86 Arg2:E66
T87 Medication 1830 1834 IVIG
E67 Medication:T87
T88 Activity 1854 1860 fluids
E68 Activity:T88
A8 POLARITY E68 NEG
T89 Activity 1862 1866 food
E69 Activity:T89
A9 POLARITY E69 NEG
T90 Medication 1872 1882 medication
E70 Medication:T90
A10 POLARITY E70 NEG
T91 Clinical_event 1892 1900 detained
E71 Clinical_event:T91
T92 Detailed_description 1911 1931 UK Mental Health Act
R44 MODIFY Arg1:T92 Arg2:E71
T93 Diagnostic_procedure 1940 1943 MRI
E72 Diagnostic_procedure:T93
T94 Sign_symptom 2002 2022 signal abnormalities
E73 Sign_symptom:T94
T95 Detailed_description 1989 2001 nonenhancing
T96 Detailed_description 1984 1987 new
R45 MODIFY Arg1:T95 Arg2:E73
R46 MODIFY Arg1:T96 Arg2:E73
T97 Detailed_description 184 188 DQB1
R47 MODIFY Arg1:T97 Arg2:T11
T98 Detailed_description 221 228 in vivo
R48 MODIFY Arg1:T98 Arg2:E7
T99 Biological_structure 2026 2038 both thalami
T100 Biological_structure 2043 2051 midbrain
R49 MODIFY Arg1:T99 Arg2:E73
R50 MODIFY Arg1:T100 Arg2:E73
T101 Biological_structure 2057 2070 cranial nerve
R51 MODIFY Arg1:T101 Arg2:E73
T102 Sign_symptom 2100 2111 enhancement
E74 Sign_symptom:T102
A11 POLARITY E74 NEG
T103 Biological_structure 2090 2099 meningeal
R52 MODIFY Arg1:T103 Arg2:E74
T104 Date 2126 2150 Near the end of December
E75 Date:T104
T105 Diagnostic_procedure 2167 2173 biopsy
E76 Diagnostic_procedure:T105
T106 Biological_structure 2154 2166 frontal lobe
R53 MODIFY Arg1:T106 Arg2:E76
T107 Diagnostic_procedure 2189 2198 Histology
E77 Diagnostic_procedure:T107
T108 Sign_symptom 2217 2224 gliosis
E78 Sign_symptom:T108
T109 Detailed_description 2208 2216 reactive
R54 MODIFY Arg1:T109 Arg2:E78
T110 Sign_symptom 2237 2249 infiltration
E79 Sign_symptom:T110
T111 Detailed_description 2229 2236 diffuse
R55 MODIFY Arg1:T111 Arg2:E79
T112 Detailed_description 2255 2274 CD3+/8+ lymphocytes
R56 MODIFY Arg1:T112 Arg2:E79
T113 Diagnostic_procedure 2298 2321 microbiological testing
E80 Diagnostic_procedure:T113
T114 Detailed_description 2329 2342 biopsy tissue
R57 MODIFY Arg1:T114 Arg2:E80
T115 Lab_value 2374 2382 negative
E81 Lab_value:T115
T116 Detailed_description 2350 2369 infectious etiology
R58 MODIFY Arg1:T116 Arg2:E80
R59 MODIFY Arg1:E81 Arg2:E80
T117 Disease_disorder 2471 2497 neurological deterioration
E82 Disease_disorder:T117
A12 TREND E82 INC
T118 Diagnostic_procedure 2572 2598 next-generation sequencing
E83 Diagnostic_procedure:T118
T119 Diagnostic_procedure 2600 2603 NGS
E84 Diagnostic_procedure:T119
R60 IDENTICAL Arg1:E84 Arg2:E83
T120 Detailed_description 2560 2571 metagenomic
R61 MODIFY Arg1:T120 Arg2:E83
T121 Date 2544 2556 January 2014
E85 Date:T121
T122 Detailed_description 2499 2526 CSF and brain biopsy tissue
R62 MODIFY Arg1:T122 Arg2:E83
T123 Diagnostic_procedure 2610 2613 NGS
E86 Diagnostic_procedure:T123
T124 Detailed_description 2630 2642 brain biopsy
R63 MODIFY Arg1:T124 Arg2:E86
T125 Diagnostic_procedure 2644 2659 genome assembly
E87 Diagnostic_procedure:T125
R64 SUB_PROCEDURE Arg1:E87 Arg2:E86
T126 Diagnostic_procedure 2665 2686 in situ hybridization
E88 Diagnostic_procedure:T126
T127 Disease_disorder 2722 2732 astrovirus
E89 Disease_disorder:T127
T128 Disease_disorder 2734 2738 AstV
E90 Disease_disorder:T128
R65 IDENTICAL Arg1:E90 Arg2:E89
T129 Detailed_description 2708 2721 neuroinvasive
R66 MODIFY Arg1:T129 Arg2:E89
T130 Medication 2816 2825 ribavirin
E91 Medication:T130
T131 Medication 2830 2834 IVIG
E92 Medication:T131
T132 Sign_symptom 2906 2931 minimally conscious state
E93 Sign_symptom:T132
T133 Medication 2956 2964 sedation
E94 Medication:T133
A13 POLARITY E94 NEG
T134 Date 2968 2978 March 2014
E95 Date:T134
T135 Date 3018 3032 4 months after
E96 Date:T135
T136 Diagnostic_procedure 3037 3040 NGS
E97 Diagnostic_procedure:T136
T137 Date 3069 3085 7.5 months after
E98 Date:T137
T138 Sign_symptom 3095 3103 symptoms
E99 Sign_symptom:T138
R67 BEFORE Arg1:E1 Arg2:E2
* OVERLAP E2 E3 E4 E7
R68 BEFORE Arg1:E7 Arg2:E8
* OVERLAP E8 E9
R69 AFTER Arg1:E9 Arg2:E10
R70 BEFORE Arg1:E10 Arg2:E11
* OVERLAP E11 E12 E13 E14
R71 BEFORE Arg1:E14 Arg2:E16
* OVERLAP E16 E17 E18 E19 E20 E22 E24 E38 E47 E48
R72 BEFORE Arg1:E48 Arg2:E39
* OVERLAP E39 E40 E41
R73 BEFORE Arg1:E41 Arg2:E42
* OVERLAP E42 E43 E44 E45
T139 Detailed_description 1194 1202 postural
R74 MODIFY Arg1:T139 Arg2:E43
R75 BEFORE Arg1:E45 Arg2:E50
* OVERLAP E50 E51 E52
T140 Sign_symptom 1353 1360 symptom
E100 Sign_symptom:T140
R76 AFTER Arg1:E52 Arg2:E100
R77 BEFORE Arg1:E100 Arg2:E53
* OVERLAP E53 E54 E55 E56 E57 E58 E60 E62 E63 E64 E65 E66 E67
R78 BEFORE Arg1:E67 Arg2:E68
* OVERLAP E68 E69 E70
R79 BEFORE Arg1:E70 Arg2:E71
* OVERLAP E71 E72 E73 E74
R80 BEFORE Arg1:E74 Arg2:E75
* OVERLAP E75 E76 E77 E78 E79 E80 E82
R81 BEFORE Arg1:E82 Arg2:E85
* OVERLAP E85 E83 E86 E88 E89
R82 BEFORE Arg1:E89 Arg2:E91
* OVERLAP E91 E92
R83 BEFORE Arg1:E92 Arg2:E93
* OVERLAP E93 E94 E95
R84 BEFORE Arg1:E95 Arg2:E5
* OVERLAP E5 E6 E96
R85 AFTER Arg1:E96 Arg2:E97
R86 BEFORE Arg1:E97 Arg2:E98
R87 AFTER Arg1:E98 Arg2:E99